The New York Proton Center is joining the first national randomized clinical trial to evaluate the efficacy of proton therapy compared to traditional radiotherapy for patients with locally advanced breast cancer.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
